April 10, 2017
Q1 2017 investments: companies we backed
I’m excited to share the companies we invested in in Q1 and why.
- Mission Bio (bridge to Series A): CEO Charlie Silver and his team provide tools for the study of cellular heterogeneity in human health and life science research. Find out more at www.missionbio.com.
- Hospicorp (Series B): CEO Igal Ladabaum and his team provide medical devices that enhance patient comfort and well being, ease caregiver burden, and reduce cost. Find out more at www.hospicorp.com.
- Glue Networks (Series A): CEO Jeff Gray and his team provide a network orchestration solution. Find out more at www.gluenetworks.com.
If you or someone you know runs a Bay Area-based company raising a bridge to series A, or a series A, we’d love to hear from you. The best way to get in touch with us is via a mutual connection, most likely a current investor or your law firm. If that’s not an option, then email firstname.lastname@example.org.